Natera to Participate in the Canaccord Genuity 44th Annual Growth Conference
06 August 2024 - 3:00PM
Business Wire
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA
testing, today announced that members of its leadership team will
present at the Canaccord Genuity 44th Annual Growth Conference on
Wednesday, Aug. 14 at 12:30 pm ET | 9:30 am PT in Boston, MA.
A live webcast and audio archive of the event may be accessed
through the investor relations section of the Natera website at
investor.natera.com. A replay of the event will be available
shortly following the conference.
About Natera
Natera™ is a global leader in cell-free DNA and genetic testing,
dedicated to oncology, women’s health, and organ health. We aim to
make personalized genetic testing and diagnostics part of the
standard of care to protect health, and inform earlier, more
targeted interventions that help lead to longer, healthier lives.
Natera’s tests are validated by more than 200 peer-reviewed
publications that demonstrate high accuracy. Natera operates ISO
13485-certified and CAP-accredited laboratories certified under the
Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas
and San Carlos, California. For more information, visit
www.natera.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240806007030/en/
Investor Relations: Mike Brophy, CFO, Natera, Inc.,
510-826-2350, investor@natera.com Media: Lesley Bogdanow, VP of
Corporate Communications, Natera, Inc., pr@natera.com
Natera (NASDAQ:NTRA)
Historical Stock Chart
Von Sep 2024 bis Okt 2024
Natera (NASDAQ:NTRA)
Historical Stock Chart
Von Okt 2023 bis Okt 2024